Effectiveness of Rituximab in Pediatric OMS Patients.

Clinical trial NCT00244361 · COMPLETED

Trial details

NCT number: NCT00244361
Sponsor: National Pediatric Neuroinflammation Organization, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Opsoclonus-myoclonus Syndrome Opsoclonus Myoclonus Ataxia

Start date: 2005-06-01
Primary completion: 2007-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.